Cargando…
Electroconvulsive therapy treatment in patients with somatic symptom and related disorders
OBJECTIVE: Medically unexplained somatic complaints are highly prevalent, and lead to significant impairment and disability. The number of effective treatment modalities for somatic symptom and related disorders (SSDs) or somatoform disorders (SDs) remains limited. To date, there is no formal indica...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605246/ https://www.ncbi.nlm.nih.gov/pubmed/26504388 http://dx.doi.org/10.2147/NDT.S90969 |
_version_ | 1782395177586917376 |
---|---|
author | Leong, KaWai Tham, Joseph CW Scamvougeras, Anton Vila-Rodriguez, Fidel |
author_facet | Leong, KaWai Tham, Joseph CW Scamvougeras, Anton Vila-Rodriguez, Fidel |
author_sort | Leong, KaWai |
collection | PubMed |
description | OBJECTIVE: Medically unexplained somatic complaints are highly prevalent, and lead to significant impairment and disability. The number of effective treatment modalities for somatic symptom and related disorders (SSDs) or somatoform disorders (SDs) remains limited. To date, there is no formal indication for electroconvulsive therapy (ECT) in SSD or SD. We report on the largest case series to date regarding the effectiveness of ECT in patients with SSD and SD. METHODS: A retrospective chart review of all patients treated with an index course of ECT at the Neuropsychiatric Program at the University of British Columbia Hospital from 2000 to 2010 was conducted. The primary outcomes consisted of changes in pseudoneurologic symptoms, pain symptoms, cardiopulmonary symptoms, and gastrointestinal symptoms. Complaints were examined pre- and post-ECT. RESULTS: Twenty-eight participants were included in this study. Twenty-one participants received right unilateral ECT. Six received bifrontal ECT. One received bitemporal ECT. Eighteen of 21 participants reported improvement in pseudoneurologic symptoms; eleven of 14 participants reported improvement in pain symptoms; one participant reported improvement in cardiopulmonary symptoms; and one of two participants reported improvement in gastrointestinal symptoms. This paper discusses the putative mechanism of action of ECT in the treatment of SD/SSD. CONCLUSION: This retrospective study suggests that ECT could be included as part of the existing treatment for refractory SSD and SD, particularly in refractory cases with comorbid mood disorders. |
format | Online Article Text |
id | pubmed-4605246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-46052462015-10-26 Electroconvulsive therapy treatment in patients with somatic symptom and related disorders Leong, KaWai Tham, Joseph CW Scamvougeras, Anton Vila-Rodriguez, Fidel Neuropsychiatr Dis Treat Original Research OBJECTIVE: Medically unexplained somatic complaints are highly prevalent, and lead to significant impairment and disability. The number of effective treatment modalities for somatic symptom and related disorders (SSDs) or somatoform disorders (SDs) remains limited. To date, there is no formal indication for electroconvulsive therapy (ECT) in SSD or SD. We report on the largest case series to date regarding the effectiveness of ECT in patients with SSD and SD. METHODS: A retrospective chart review of all patients treated with an index course of ECT at the Neuropsychiatric Program at the University of British Columbia Hospital from 2000 to 2010 was conducted. The primary outcomes consisted of changes in pseudoneurologic symptoms, pain symptoms, cardiopulmonary symptoms, and gastrointestinal symptoms. Complaints were examined pre- and post-ECT. RESULTS: Twenty-eight participants were included in this study. Twenty-one participants received right unilateral ECT. Six received bifrontal ECT. One received bitemporal ECT. Eighteen of 21 participants reported improvement in pseudoneurologic symptoms; eleven of 14 participants reported improvement in pain symptoms; one participant reported improvement in cardiopulmonary symptoms; and one of two participants reported improvement in gastrointestinal symptoms. This paper discusses the putative mechanism of action of ECT in the treatment of SD/SSD. CONCLUSION: This retrospective study suggests that ECT could be included as part of the existing treatment for refractory SSD and SD, particularly in refractory cases with comorbid mood disorders. Dove Medical Press 2015-10-06 /pmc/articles/PMC4605246/ /pubmed/26504388 http://dx.doi.org/10.2147/NDT.S90969 Text en © 2015 Leong et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Leong, KaWai Tham, Joseph CW Scamvougeras, Anton Vila-Rodriguez, Fidel Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title | Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title_full | Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title_fullStr | Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title_full_unstemmed | Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title_short | Electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
title_sort | electroconvulsive therapy treatment in patients with somatic symptom and related disorders |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605246/ https://www.ncbi.nlm.nih.gov/pubmed/26504388 http://dx.doi.org/10.2147/NDT.S90969 |
work_keys_str_mv | AT leongkawai electroconvulsivetherapytreatmentinpatientswithsomaticsymptomandrelateddisorders AT thamjosephcw electroconvulsivetherapytreatmentinpatientswithsomaticsymptomandrelateddisorders AT scamvougerasanton electroconvulsivetherapytreatmentinpatientswithsomaticsymptomandrelateddisorders AT vilarodriguezfidel electroconvulsivetherapytreatmentinpatientswithsomaticsymptomandrelateddisorders |